HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,008 | -83.6% | 52,558 | -84.5% | 0.02% | -81.0% |
| Q2 2023 | $12,262 | +108.7% | 339,963 | +121.0% | 0.10% | +104.1% |
| Q1 2023 | $5,876 | +6.2% | 153,852 | +58.2% | 0.05% | -38.8% |
| Q4 2022 | $5,533 | -99.9% | 97,248 | -1.8% | 0.08% | +56.9% |
| Q3 2022 | $3,914,000 | -44.5% | 98,983 | -38.2% | 0.05% | -40.7% |
| Q2 2022 | $7,052,000 | +38.3% | 160,279 | +25.3% | 0.09% | +34.4% |
| Q1 2022 | $5,099,000 | +129.6% | 127,868 | +131.5% | 0.06% | +178.3% |
| Q4 2021 | $2,221,000 | +65.6% | 55,232 | +71.7% | 0.02% | +15.0% |
| Q1 2021 | $1,341,000 | -1.1% | 32,161 | -37.7% | 0.02% | -25.9% |
| Q3 2020 | $1,356,000 | +4.1% | 51,617 | +6.3% | 0.03% | -20.6% |
| Q2 2020 | $1,302,000 | +171.8% | 48,563 | +79.7% | 0.03% | +277.8% |
| Q4 2019 | $479,000 | – | 27,032 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |